UCB presents award for neuroscience in Belgium
The UCB Award for Neuroscientific Research in Belgium has been presented to the research group of Pierre Vanderhaeghen of the Institut de Recherches Interdisciplinaires en Biologie Humaine et Moleculaire (IRIBHM), Universite Libre de Bruxelles. This Award recognises the team's outstanding contribution to neuroscience and the understanding of the mechanisms that control the size and shape of the brain.
Her Royal Highness Princess Astrid, Honorary President of the Queen Elizabeth Medical Foundation, presented the UCB Award at the Royal Palace in Brussels.
Dr Vanderhaeghen is leading one of the 17 university teams which received a substantial annual grant from the Queen Elisabeth Medical Foundation, which focuses on neuroscience and supports researchers using the latest techniques to study the functioning of the nervous system.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze